论文期刊

取消

高级检索

检索历史清除

首页> Gut> FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma.

FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Ning,Lyu ^[1] ; Youen,Lin ^[2] ; Yanan,Kong ^[3] ; Zhenfeng,Zhang ^[1] ; Longzhong,Liu ^[1] ; Lie,Zheng ^[1] ; Luwen,Mu ^[1] ; Jianpeng,Wang ^[4] ; Xishan,Li ^[5] ; Tao,Pan ^[1] ; Qiankun,Xie ^[1] ; Yaru,Liu ^[1] ; Aihua,Lin ^[6] ; Peihong,Wu ^[1] ; Ming,Zhao ^[1]

作者单位： Division of Minimally Invasive Interventional, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[1] Department of Interventional Radiology, Jieyang Affiliated Hospital, Sun Yat-sen University, Jieyang, China. ^[2] State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China. ^[3] Department of Minimally Invasive Interventional and Target Treatment, Affiliated Foshan Hospital of Sun Yat-sen University, Foshan, China. ^[4] Department of Interventional Radiology, First People's Hospital, Guangzhou, China. ^[5] Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China. ^[6]

关键词 Advanced HCC FOLFOX HAIC

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 肝细胞(Carcinoma, Hepatocellular);顺铂(Cisplatin);氟尿嘧啶(Fluorouracil);人类(Humans);醛氢叶酸(Leucovorin);肝肿瘤(Liver Neoplasms);有机铂化合物(Organoplatinum Compounds);治疗结果(Treatment Outcome)

DOI 10.1136/gutjnl-2017-314138

PMID 28592441

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Gut

Gut

2018年67卷2期

395-396页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷